Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypofractionated RT + Chemo + Thymosin α1 in Thymic Epithelial Tumors
NCT03663764Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2018
- Primary completion
- Aug 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in thymic epithelial tumor (TET), thymic neuroendocrine tumor (tNEN), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
thymosin alpha 1
03
Conditions
thymic epithelial tumor (TET)thymic neuroendocrine tumor (tNEN)
Beyond the preview
Go deeper on NCT03663764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663764.